These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

119 related articles for article (PubMed ID: 9950255)

  • 1. Suppression of Fas receptor and negative correlation of Fas ligand with differentiation and apoptosis in oral squamous cell carcinoma.
    Loro LL; Vintermyr OK; Johannessen AC; Liavaag PG; Jonsson R
    J Oral Pathol Med; 1999 Feb; 28(2):82-7. PubMed ID: 9950255
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of FasL expression in oral squamous cell cancer.
    Fang L; Sun L; Hu FF; Chen QE
    Asian Pac J Cancer Prev; 2013; 14(1):281-5. PubMed ID: 23534738
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Oral squamous cell carcinoma is associated with decreased bcl-2/bax expression ratio and increased apoptosis.
    Loro LL; Vintermyr OK; Liavaag PG; Jonsson R; Johannessen AC
    Hum Pathol; 1999 Sep; 30(9):1097-105. PubMed ID: 10492046
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A Fas Ligand (FasL)-Fused Humanized Antibody Against Tumor-Associated Glycoprotein 72 Selectively Exhibits the Cytotoxic Effect Against Oral Cancer Cells with a Low FasL/Fas Ratio.
    Chien MH; Chang WM; Lee WJ; Chang YC; Lai TC; Chan DV; Sharma R; Lin YF; Hsiao M
    Mol Cancer Ther; 2017 Jun; 16(6):1102-1113. PubMed ID: 28292939
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expression of ADAM10, Fas, FasL and Soluble FasL in Patients with Oral Squamous Cell Carcinoma (OSCC) and their Association with Clinical-Pathological Parameters.
    Zepeda-Nuño JS; Guerrero-Velázquez C; Del Toro-Arreola S; Vega-Magaña N; Ángeles-Sánchez J; Haramati J; Pereira-Suárez AL; Bueno-Topete MR
    Pathol Oncol Res; 2017 Apr; 23(2):345-353. PubMed ID: 27628319
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Expression of fas (CD95) ligand is correlated with IL-10 and granulocyte colony-stimulating factor expression in oral and oropharyngeal squamous cell carcinoma.
    Fujieda S; Sunaga H; Tsuzuki H; Fan GK; Ito T; Sugimoto C; Saito H
    Cancer Lett; 2000 Dec; 161(1):73-81. PubMed ID: 11078915
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Up-regulation of Fas ligand and down-regulation of Fas expression in oral carcinogenesis.
    Chen Q; Samaranayake LP; Zhen X; Luo G; Nie M; Li B
    Oral Oncol; 1999 Nov; 35(6):548-53. PubMed ID: 10705088
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repression of tumor necrosis factor-related apoptosis-inducing ligand (TRAIL) but not its receptors during oral cancer progression.
    Vigneswaran N; Baucum DC; Wu J; Lou Y; Bouquot J; Muller S; Zacharias W
    BMC Cancer; 2007 Jun; 7():108. PubMed ID: 17592646
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The relationship of Fas and Fas L protein expression in oral carcinogenesis].
    Zeng X; Chen Q; Nie M
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2003 Aug; 21(4):259-62. PubMed ID: 14513577
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Fas counterattack in vivo: apoptotic depletion of tumor-infiltrating lymphocytes associated with Fas ligand expression by human esophageal carcinoma.
    Bennett MW; O'Connell J; O'Sullivan GC; Brady C; Roche D; Collins JK; Shanahan F
    J Immunol; 1998 Jun; 160(11):5669-75. PubMed ID: 9605174
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Study on the relationship between Fas expression and apoptosis in oral squamous cell carcinoma].
    Wang JG; Huang HZ; Pan CB; Hou JS; Li JS; Cheng B
    Hua Xi Kou Qiang Yi Xue Za Zhi; 2004 Aug; 22(4):334-6. PubMed ID: 15379323
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fas ligand and Fas receptor are coexpressed in normal human esophageal epithelium: a potential mechanism of apoptotic epithelial turnover.
    Bennett MW; O'Connell J; O'Sullivan GC; Roche D; Brady C; Collins JK; Shanahan F
    Dis Esophagus; 1999; 12(2):90-8. PubMed ID: 10466040
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Alteration of Fas/FasL gene expression in oral squamous cell carcinoma cell line Tca83 by retinoid acid].
    Guan W; Yu S; Gao Y
    Zhonghua Kou Qiang Yi Xue Za Zhi; 2001 May; 36(3):215-8. PubMed ID: 11812347
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Maintained CD40 and loss of polarised CD40 ligand expression in oral squamous cell carcinoma.
    Loro LL; Ohlsson M; Vintermyr OK; Liavaag PG; Jonsson R; Johannessen AC
    Anticancer Res; 2001; 21(1A):113-7. PubMed ID: 11299724
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Up-regulation of fas ligand at early stages and down-regulation of Fas at progressed stages of intrahepatic cholangiocarcinoma reflect evasion from immune surveillance.
    Shimonishi T; Isse K; Shibata F; Aburatani I; Tsuneyama K; Sabit H; Harada K; Miyazaki K; Nakanuma Y
    Hepatology; 2000 Oct; 32(4 Pt 1):761-9. PubMed ID: 11003620
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Up-regulation of Fas (APO-1/CD95) ligand and down-regulation of Fas expression in human esophageal cancer.
    Gratas C; Tohma Y; Barnas C; Taniere P; Hainaut P; Ohgaki H
    Cancer Res; 1998 May; 58(10):2057-62. PubMed ID: 9605741
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Fas ligand-positive membranous vesicles isolated from sera of patients with oral cancer induce apoptosis of activated T lymphocytes.
    Kim JW; Wieckowski E; Taylor DD; Reichert TE; Watkins S; Whiteside TL
    Clin Cancer Res; 2005 Feb; 11(3):1010-20. PubMed ID: 15709166
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Signaling abnormalities, apoptosis, and reduced proliferation of circulating and tumor-infiltrating lymphocytes in patients with oral carcinoma.
    Reichert TE; Strauss L; Wagner EM; Gooding W; Whiteside TL
    Clin Cancer Res; 2002 Oct; 8(10):3137-45. PubMed ID: 12374681
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas receptor (CD95) & Fas ligand (CD178) expression in patients with tobacco-related intraoral squamous cell carcinoma.
    Das SN; Khare P; Singh MK; Sharma SC
    Indian J Med Res; 2011 Jul; 134(1):54-60. PubMed ID: 21808135
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of Fas/FasL in patients with oral lichen planus.
    Hadzi-Mihailovic M; Raybaud H; Monteil R; Jankovic L
    J BUON; 2009; 14(3):487-93. PubMed ID: 19810143
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.